McAvoy, Malia http://orcid.org/0000-0002-9998-4737
Bui, Ai-Tram N. http://orcid.org/0000-0003-0133-7935
Hansen, Christopher http://orcid.org/0000-0002-6640-2745
Plana, Deborah http://orcid.org/0000-0002-4218-1693
Said, Jordan T. http://orcid.org/0000-0002-0357-6916
Yu, Zizi http://orcid.org/0000-0001-8566-0777
Yang, Helen http://orcid.org/0000-0002-9455-5300
Freake, Jacob http://orcid.org/0000-0002-5198-835X
Van, Christopher http://orcid.org/0000-0003-3262-964X
Krikorian, David
Cramer, Avilash http://orcid.org/0000-0003-0014-8921
Smith, Leanne
Jiang, Liwei http://orcid.org/0000-0002-1863-6803
Lee, Karen J. http://orcid.org/0000-0003-4255-8355
Li, Sara J.
Beller, Brandon
Huggins, Kimberley
Short, Michael P. http://orcid.org/0000-0002-9216-2482
Yu, Sherry H. http://orcid.org/0000-0002-1432-9128
Mostaghimi, Arash http://orcid.org/0000-0002-6084-5617
Sorger, Peter K. http://orcid.org/0000-0002-3364-1838
LeBoeuf, Nicole R. http://orcid.org/0000-0002-8264-834X
Funding for this research was provided by:
Harvard MIT Center for Regulatory Sciences (Harvard MIT Center for Regulatory Sciences)
National Cancer Institute (U54-CA225088, U54-CA225088, U54-CA225088)
National Institute of General Medical Sciences (T32-GM007753)
Article History
Received: 23 July 2020
Accepted: 9 May 2021
First Online: 7 June 2021
Declarations
:
: The Partners Healthcare Institutional Review Board (Office for Human Research Protections registration numbers IRB00012706 and IRB00012707) approved this study (protocol #2020P001209). Consent was not written; instead, all volunteers provided verbal informed consent. Verbal consent was obtained from study subjects due to the COVID-19 pandemic to minimize contact transfer of objects between participants. The Partners Healthcare Institutional Review Board approved this procedure.
: Consent for publication has been obtained from the study participants. Written informed consent for publication was obtained from the study participants pictured in Fig. InternalRef removed and Additional Material InternalRef removed.
: A Mostaghimi is a consultant or has received honoraria from Pfizer, 3Derm, and hims and has equity in Lucid Dermatology and hims. He is an associate editor for JAMA Dermatology. Mostaghimi declares that none of these relationships are directly or indirectly related to the content of this manuscript.PK Sorger is a member of the SAB or Board of Directors of Applied Biomath, Glencoe Software and RareCyte Inc and has equity in these companies. In the last five years the Sorger lab has received research funding from Novartis and Merck. Sorger declares that none of these relationships are directly or indirectly related to the content of this manuscript.NR LeBoeuf is a consultant for or has received honoraria from the following companies: Seattle Genetics, Sanofi, Bayer, Seattle Genetics, Sanofi, Silverback and Synox Therapeutics outside the submitted work.